Scotts Miracle-Gro outlines SMG 2.0 targets and capital plan for 2027-29
Aug 4, 2026, 6:53 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The roadmap combines steady top-line growth with margin expansion and stronger FCF, plus a disciplined capital-allocation framework. If investors view the targets as achievable and balance-sheet goals as credible, SMG could see a positive re-rating and earnings multiple expansion, particularly ahead of or following Investor Day.
AI summary
What happened, with direct paths to the underlying reporting
Scotts Miracle-Gro detailed its SMG 2.0 growth strategy and mid-term targets for 2027-2029 at Investor Day, highlighting steady top-line growth, margin expansion, and robust free cash flow. The plan prioritizes portfolio revamps, omnichannel expansion, and technology-enabled efficiency alongside a disciplined capital-allocation framework. If execution aligns with the targets, SMG could see improved profitability and a stronger balance sheet over the 2027-2029 horizon.
SMG reveals SMG 2.0 targets for 2027-2029. Targets include 2-4% net sales growth.
Adj. gross margin up 50-100 bps; adj. EPS up 5-8%.
FCF >$275M; leverage target 3.0-3.5x for 2027-2029.
Capital allocation emphasizes tech/R&D, dividends, and buybacks.
Investor Day 2026 outlines disciplined path with debt reduction focus.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Jim Cramer has recommended avoiding tobacco stocks, particularly Altria Group (NYSE:MO), while highlighting the increasing demand for LNG as a potential growth driver for companie…
SMG's Q2 2025 EPS rose 8% to $3.98, above consensus. Sales fell 7% year-over-year to $1.42 billion, missing expectations. U.S. consumer sales decreased 5%, affected by a slow lawn…
Scotts Miracle-Gro plans to separate Hawthorne to boost its valuation. Hawthorne's sales fell 35% to $52 million in the first fiscal quarter. Analyst sees separation as a positive…
- Scotts Miracle-Gro reported $1.53 billion revenue, down 0.4% from last year. - EPS was $3.69 compared to $3.78 in the previous year. - Net sales varied for different segments, i…